文档库 最新最全的文档下载
当前位置:文档库 › 2012非ST段抬高急性冠状动脉综合征诊断和治疗指南

2012非ST段抬高急性冠状动脉综合征诊断和治疗指南

万方数据

万方数据

万方数据

万方数据

万方数据

万方数据

万方数据

万方数据

万方数据

万方数据

万方数据

万方数据

万方数据

万方数据

万方数据

非ST段抬高急性冠状动脉综合征诊断和治疗指南

作者:中华医学会心血管病学分会, 中华心血管病杂志编辑委员会

作者单位:

刊名:

中华心血管病杂志

英文刊名:Chinese Journal of Cardiology

年,卷(期):2012,40(5)

参考文献(98条)

1.Dixon SR;Grines CL The year in interventional cardiology 2011

2.Fox KA;Clayton TC;Damman P Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual

patient data 2010

3.Wright RS;Anderson JL;Adams CD2011 ACCF/AHA focused update of the Guidelines for the management

of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline):a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the American College of Emergency Physicians,Society for Cardiovascular Angio 2011

4.Hamm CW;Bassand JP;Agewall S ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) 2011

5.中华医学会心血管病学分会;《中华心血管病杂志》编辑委员会不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南 2007

6.中华医学会心血管病学分会;《中华心血管病杂志》编辑委员会急性ST段抬高型心肌梗死诊断与治疗指南 2010

7.Libby P;Bonow RO Braunwald's Heart Disease 2008

8.Fraker TD Jr;Fihn SD;Gibbons RJ2007 Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina:a report of the American College of Cardiology/American Heart Association task force on practice guidelines writing group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina 2007 9.Anderson JL;Adams CD;Antman EM ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST elevation myocardial infarction:a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction) 2007

10.Okamatsu K;Takano M;Sakai S Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes 2004

11.Bonaca MP;Wiviott SD;Braunwald E American College of Cardiology/American Heart

Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death:observations from the TRITON-TIMI 38 trial (trial to assess improvement in therapeutic outcomes by optimizing platelet

inhibition with prasugrel-thrombolysis in myocardial i 2012

12.Granger CB;Goldberg RJ;Dabbous O Predictors of hospital mortality in the global registry of acute coronary events 2003

13.Yan RT;Yan AT;Mahaffey KW Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromes 2009

14.Szyma(n)ski FM;Grabowski M;Filipiak KJ Admission ST-segment elevation in lead aVR as the factor improving complex risk stratification in acute coronary syndromes 2008

15.Thygesen K;Mair J;Katus H Recommendations for the use of cardiac tmponin measurement in acute cardiac care 2010

16.Thygesen K;Mair J;Mueller C Recommendations for the use of natriuretic peptides in acute cardiac care:a position statement from the study group on biomarkers in cardiology of the ESC working group on acute cardiac care 2011

17.Khan SQ;Narayan H;Ng KH N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late morality following acute coronary syndrome 2009

18.Antman EM;Cohen M;Bernink PJ The TIMI risk score for unstable angina/non-ST elevation MI:a method for prognostication and therapeutic decision making 2000

19.Fox KA;Dabbous OH;Goldberg RJ Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)[外文期刊] 2006

20.Subherwal S;Bach RG;Chen AY Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction:the CRUSADE (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines) bleeding score 2009 21.Mehran R;Pocock SJ;Nikolsky E A risk score to predict bleeding in patients with acute coronary syndromes 2010

https://www.wendangku.net/doc/ef6715939.html,ler CD;Roe MT;Mulgund J Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction 2007

23.中华医学会心血管病学分会;《中华心血管病杂志》编辑委员会β肾上腺素能受体阻滞剂在心血管疾病应用专家共识 2009

24.Dagenais GR;Pogue J;Fox K Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure:a combined analysis of three trials 2006

25.IONA study group Effect of nicorandil on coronary events in patients with stable angina:the impact of nicorandil in angina (IONA) randomized trial 2002

26.Antithrombotic trialists' (ATT) collaboration;Baigent C;Blackwell L Aspirin in the primary and secondary prevention of vascular disease:collaborative meta-analysis of individual participant data from randomized trials 2009

27.Bhatt DL;Cryer BL;Contant CF Clopidogrel with or without omeprazole in coronary artery disease[外

文期刊] 2010

28.Wallentin L;Becker RC;Budaj A Ticagrelor versus clopidogrel in patients with acute coronary syndromes[外文期刊] 2009(11)

29.Wiviott S;Braunwald E;McCabe C Prasugrel versus clopidogrel in patients with acute coronary syndromes 2007

30.CURRENT-OASIS 7 Investigators;Mehta SR;Bassand JP Dose comparisons of clopidogrel and aspirin in acute coronary syndromes 2010

31.Mega JL;Close SL;Wiviott SD Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial:a pharmacogenetic analysis 2010

32.Breet N;van Werkum J;Bouman H Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation 2010

33.Kastrati A;Mehilli J;Neumann FJ Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment:the ISAR-REACT 2 randomized trial [外文期刊] 2006

34.Valgimigli M;Biondi-Zoccai G;Tebaldi M Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention:a meta-analysis of randomized trials 2010

35.Neumann FJ;Kastrati A;Pogatsa-Murray G Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy)before intervention in patients with unstable coronary syndromes:a randomized controlled trial 2003

36.Stone GW;Bertrand ME;Moses JW Routine upstream initiation vs deferred selective use of glycoprotein Ⅱ b/Ⅲ a inhibitors in acute coronary syndromes:the ACUITY timing trial 2007

37.Giugliano RP;White JA;Bode C Early versus delayed,provisional eptifibatide in acute coronary syndromes 2009

38.Berger JS;Frye CB;Harshaw Q Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery:a multicenter analysis[外文期刊] 2008(21)

39.Grines CL;Bonow RO;Casey DE Jr Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents:a science advisory from the American Heart Association,American College of Cardiology,Society for Cardiovascular Angiography and Interventions,American College of Surgeons,and American Dental Association,with representation from the American College of Physicians 2007

40.Harrington RA;Becker RC;Cannon CP Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes:American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) 2008

41.Fifth organization to assess strategies in acute ischemic syndromes investigators;Yusuf S;Mehta SR Comparison of fondaparinux and enoxaparin in acute coronary syndromes 2006

42.FUTURA/OASIS-8 trial group;Steg PG;Jolly SS Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux:the

FUTURA/OASIS-8 randomized trial 2010

43.Petersen JL;Mahaffey KW;Hasselblad V Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes:a systematic overview 2004

44.Stone GW;Mclaurin BT;Cox DA Bivalirudin for patients with acute coronary syndromes 2006

45.Stone GW;White HD;Ohman EM Acute catheterization and urgent intervention triage strategy (ACUITY) trial investigators.Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the acute catheterization and urgent intervention triage strategy (ACUITY) trial 2007

46.Cohen M;Demers C;Gurfinkel EP A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events study group 1997

47.Hirsh J;Raschke R Heparin and low-molecular-weight heparin:the seventh ACCP conference on antithrombotic and thrombolytic therapy 2004

48.Lip GY;Huber K;Andreotti F Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting:executive summary-a consensus document of the European Society of Cardiology working group on thrombosis,endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) 2010

49.APPRAISE steering committee and investigators;Alexander JH;Becker RC Apixaban,an

oral,direct,selective factor Xa inhibitor,in combination with antiplatelet therapy after acute coronary syndrome:results of the apixaban for prevention of acute ischemic and safety events (APPRAISE) trial 2009

50.Mega JL;Braunwald E;Mohanavelu S Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46):a randomized,double-blind,phase Ⅱ trial 2009

51.Sabatine MS;Antman EM;Widimsky P Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI42):a randomized,double-blind,active-controlled,phase 2

trial 2009

52.Briguori C;Visconti G;Focaccio A Novel approaches for preventing or limiting events (Naples) Ⅱtrial:impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction [外文期刊] 2009

53.Pasceri V;Patti G;Nusca A Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention:results from the ARMYDA (atorvastatin for reduction of myocardial damage during angioplasty) study 2004

54.Patti G;Pasceri V;Colonna G Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention:results of the ARMYDA-ACS randomized trial[外文期刊] 2007

55.Di Sciascio G;Patti G;Pasceri V Efficacy of atorvastatin reload in patients on chronic

statin therapy undergoing percutaneous coronary intervention:results of the ARMYDARECAPTURE (atorvastatin for reduction of myocardial damage during angioplasty) randomized trial 2009

56.Patti G;Chello M;Gatto L Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Results from the ARMYDA-ACS CAMs (atorvastatin for reduction of myocardial damage during angioplasty-cell adhesion molecules)substudy 2010

57.Sever PS;Poulter NR;Dahl(o)f B Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian cardiac outcomes trial-lipid-lowering arm (ASCOT-LLA) 2005 58.Hulten E;Jackson JL;Douglas K The effect of early,intensive statin therapy on acute coronary syndrome:a meta-analysis of randomized controlled trials 2006

59.Task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS);European Association for Percutaneous Cardiovascular Interventions (EAPCI);Wijns W Guidelines on myocardial revascularization 2010

60.中华医学会心血管病分会介入心脏病学组;《中华心血管病杂志》编辑委员会中国经皮冠状动脉介入治疗指南2012(简本) 2012

61.Levine GN;Bates ER;Blankenship JC2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention.A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions [外文期刊] 2011

62.Hillis LD;Smith PK;Anderson JL2011 ACCF/AHA guideline for coronary artery bypass graft surgery.A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Developed in collaboration with the American Association for Thoracic

Surgery,Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons[外文期刊] 2011

63.Mehta SR;Granger CB;Boden WE Early versus delayed invasive intervention in acute coronary syndrome 2009

64.Montalescot G;Cayla G;Collet JP Immediate vs delayed intervention for acute coronary syndromes:a randomized clinical trial 2009

65.Sorajja P;Gersh BJ;Cox DA Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management:analysis from the ACUITY (acute catheterization and urgent intervention triage strategy) trial 2010

66.Katritsis DG;Siontis GC;Kastrati A Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes 2010

67.Damman P;Hirsch A;Windhausen F5-year clinical outcomes in the ICTUS (invasive versus conservative treatment in unstable coronary syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome 2010

68.Jiang M;He B;Zhang Q Timing of early invasive intervention in patients with moderate to high risk

相关文档